Circulating tumour cell-derived xenograft as a preclinical platform for metastatic breast cancer
- DOI
- 10.1038/s41416-026-03468-0
- Published
- 2026-05-18
- Container
- British Journal of Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41416-026-03468-0,
title = {Circulating tumour cell-derived xenograft as a preclinical platform for metastatic breast cancer},
author = {Zuzana Kahounová and Markéta Hrušková and Stanislav Drápela and Ondřej Naar and Ráchel Víchová and Jiří Navrátil and Pavel Fabian and Filip Zavadil Kokáš and Aleš Hampl and Jan Bouchal and Karel Souček},
year = {2026},
journal = {British Journal of Cancer},
doi = {10.1038/s41416-026-03468-0},
url = {https://doi.org/10.1038/s41416-026-03468-0}
}RIS
TY - JOUR TI - Circulating tumour cell-derived xenograft as a preclinical platform for metastatic breast cancer AU - Zuzana Kahounová AU - Markéta Hrušková AU - Stanislav Drápela AU - Ondřej Naar AU - Ráchel Víchová AU - Jiří Navrátil AU - Pavel Fabian AU - Filip Zavadil Kokáš AU - Aleš Hampl AU - Jan Bouchal AU - Karel Souček PY - 2026 JO - British Journal of Cancer DO - 10.1038/s41416-026-03468-0 UR - https://doi.org/10.1038/s41416-026-03468-0 ER -
APA
Kahounová, Z., Hrušková, M., Drápela, S., Naar, O., Víchová, R., Navrátil, J., Fabian, P., Kokáš, F. Z., Hampl, A., Bouchal, J., & Souček, K. (2026). Circulating tumour cell-derived xenograft as a preclinical platform for metastatic breast cancer. British Journal of Cancer. https://doi.org/10.1038/s41416-026-03468-0
Source records
- crossref · retrieved 2026-09-26T21:03:38.789Z